Free Trial

Baxter International (BAX) Stock Forecast & Price Target

Baxter International logo
$25.77 +0.97 (+3.92%)
Closing price 03:59 PM Eastern
Extended Trading
$25.65 -0.13 (-0.49%)
As of 06:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
3
Hold
9
Buy
1

Based on 13 Wall Street analysts who have issued ratings for Baxter International in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 13 analysts, 3 have given a sell rating, 9 have given a hold rating, and 1 has given a buy rating for BAX.

Consensus Price Target

$21.73
-15.70% Downside
According to the 13 analysts' twelve-month price targets for Baxter International, the average price target is $21.73. The highest price target for BAX is $27.00, while the lowest price target for BAX is $15.00. The average price target represents a forecasted downside of -15.70% from the current price of $25.77.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for BAX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Baxter International and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BAX Analyst Ratings Over Time

TypeCurrent Forecast
10/15/25 to 10/15/26
1 Month Ago
9/15/25 to 9/15/26
3 Months Ago
7/17/25 to 7/17/26
1 Year Ago
10/15/24 to 10/15/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
7 Hold rating(s)
6 Hold rating(s)
Sell
3 Sell rating(s)
2 Sell rating(s)
4 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$21.73$22.45$19.91$28.89
Forecasted Upside-15.70% Downside-5.33% Downside-11.93% Downside27.07% Upside
Consensus RatingReduceHoldReduceHold

BAX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Baxter International Stock vs. The Competition

TypeBaxter InternationalHealthcare CompaniesBroader Market
Consensus Rating Score
1.85
2.32
2.53
Consensus RatingReduceHoldModerate Buy
Predicted Upside-15.70% Downside1,140.98% Upside17.79% Upside
News Sentiment Rating
Neutral News

See Recent BAX News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/8/2026
Weiss Ratings logo
Weiss Ratings
3 of 5 stars
 DowngradeSell (D) ➝ Sell (D-)
10/7/2026
Barclays PLC logo
Barclays
3 of 5 stars
Matt Miksic
Matt Miksic
2 of 5 stars
Initiated CoverageUnderweight$20.00-17.72%
10/5/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Joanne Wuensch
Joanne Wuensch
2 of 5 stars
Lower TargetNeutral$28.00 ➝ $27.00+11.32%
8/11/2026 UpgradeStrong Sell ➝ Hold
7/31/2026Boost TargetEqual Weight$19.00 ➝ $23.00-12.59%
7/28/2026Boost TargetNeutral ➝ Hold$19.00 ➝ $25.00+2.64%
7/28/2026Boost TargetHold$19.00 ➝ $24.00-1.71%
7/27/2026Boost TargetHold$20.00 ➝ $24.00+2.98%
7/15/2026Boost TargetNeutral$19.00 ➝ $21.00-6.11%
4/6/2026 Lower TargetOutperform$23.00 ➝ $22.00+32.09%
2/13/2026 Lower TargetHold$21.00 ➝ $19.00+1.04%
12/2/2025Lower TargetUnderweight$19.00 ➝ $15.00-20.83%
10/31/2025 Lower Target$25.00 ➝ $19.00+2.90%
10/31/2025DowngradeBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:46 PM ET.


Should I Buy Baxter International Stock? BAX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 8, 2026. Please send any questions or comments about these Baxter International pros and cons to contact@marketbeat.com.

Baxter International
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Baxter International Inc.:

  • The stock is currently trading at $23.91, which is below the consensus price target of $22.45 as of September 30, 2026, suggesting potential for upside if the company meets its guidance.
  • Baxter International Inc. recently beat earnings expectations in Q2 2026, reporting $0.56 EPS against a consensus of $0.37, and raised its full-year 2026 EPS guidance to $1.95-$2.15, indicating strong operational performance.
  • The company has a low beta of 0.65, meaning it is less volatile than the overall market, which can be attractive for investors seeking stability in their portfolio.
  • Institutional investors, including BlackRock and Pzena Investment Management, have recently acquired new positions in Baxter International Inc., signaling confidence in the company's long-term prospects.
  • The company has a positive return on equity of 16.57% and a current ratio of 1.95, indicating strong profitability and liquidity, which can support future growth and dividend payments.

Baxter International
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Baxter International Inc. for these reasons:

  • The company has a negative price-to-earnings ratio of -11.55, indicating it is currently unprofitable on a trailing basis, which may deter value-oriented investors.
  • Barclays initiated coverage on Baxter International Inc. with an "underweight" rating and a $20.00 price target, suggesting potential downside of 17.72% from the current price.
  • The stock has a high debt-to-equity ratio of 1.39, which could limit the company's financial flexibility and increase risk in a rising interest rate environment.
  • The consensus rating for Baxter International Inc. is "Reduce" as of August 11, 2026, with a consensus price target of $22.45, indicating a bearish outlook from analysts.
  • The company's short interest has increased to 23.23 million shares, representing 4.5% of the float, which could indicate bearish sentiment among short sellers.

BAX Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Baxter International is $21.73, with a high forecast of $27.00 and a low forecast of $15.00.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 sell ratings, 9 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" BAX shares.

According to analysts, Baxter International's stock has a predicted downside of -15.70% based on their 12-month stock forecasts.

Over the previous 90 days, Baxter International's stock had 3 upgrades and 1 downgrade by analysts.

Baxter International has been rated by research analysts at Barclays, Citigroup, Stifel Nicolaus, TD Cowen, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.

Analysts like Baxter International less than other "healthcare" companies. The consensus rating for Baxter International is Reduce while the average consensus rating for "healthcare" companies is Hold. Learn more on how BAX compares to other companies.


MarketBeat monitors more than a dozen sources for Baxter International analyst ratings, with the most recent rating issued on 10/8/2026.
From Our Partners